Compass Therapeutics, Inc. — DEFA14A Filings
5 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Compass Therapeutics, Inc. (CMPX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Compass Therapeutics, Inc. has filed 5 DEFA14A documents with the SEC since 2018. To view all SEC filings by Compass Therapeutics, Inc., see the full filings list.
All
10-12G
10-K
10-Q
144
3
4
4/A
424B3
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
POS AM
RW
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SC 14F1/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | FORM DEFA14A | 0001171843-25-002587 | Apr 29, 2025 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001171843-24-003138 | May 29, 2024 | — |
| DEFA14A | DEFA14A | 0001140361-24-022703 | Apr 29, 2024 | — |
| DEFA14A | FORM DEFA14A | 0001140361-23-020959 | Apr 27, 2023 | — |
| DEFA14A | DEFA14A | 0001140361-22-019763 | May 18, 2022 | — |